Bangladesh has become the first country globally to be validated for the elimination of visceral leishmaniasis or kala-azar, a life-threatening neglected tropical disease.
Researchers have proven the efficacy of vaccines they created to prevent the disfiguring skin illness leishmaniasis in animal experiments, and the most promising candidate is currently undergoing preparation for a Phase 1 human trial.
London [UK], January 11 (ANI): The researchers from University of York have taken an important step forward in developing a controlled human infection model to test vaccines for one of the most neglected tropical diseases 'leishmaniasis'.
New Delhi [India], August 21 (ANI): Patients affected by Kala-Azar, scientifically called visceral leishmaniasis (VL), one of the most neglected tropical diseases may soon find relief in an oral nanomedicine from India, according to Department of Science and Technology (DST).
Hyderabad (Telangana) [India], Aug 23 (ANI): With an aim to treat fungal infections and leishmaniasis (kala-azar and black fever) prevalent in the country, researchers at Indian Institute of Technology (IIT) Hyderabad have developed a method to produce controlled-release oral tablets.
Washington D.C. [USA], Apr 15 (ANI): A recent study has claimed that with the climate getting warmer with every passing year, the geographical range of vector-borne diseases such as chikungunya, dengue fever, leishmaniasis, and tick-borne encephalitis (TBE) is expanding rapidly.
Washington D.C. [USA], August 1 (ANI): Turns out, chronic infections like hepatitis, herpes, and the Epstein-Barr virus can outsmart the human immune system.